Cancer Causes & Control

, Volume 23, Issue 4, pp 625–634

Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: a large cohort study

  • Peter D. Baade
  • Robert A. Gardiner
  • Megan Ferguson
  • Danny R. Youlden
  • Joanne F. Aitken
  • John Yaxley
  • Suzanne K. Chambers
Original paper

DOI: 10.1007/s10552-012-9931-z

Cite this article as:
Baade, P.D., Gardiner, R.A., Ferguson, M. et al. Cancer Causes Control (2012) 23: 625. doi:10.1007/s10552-012-9931-z

Abstract

Objective

To examine the relation between socio-demographic and clinical factors, and time from consultation to diagnosis and treatment for men with prostate cancer.

Methods

Men diagnosed with prostate cancer (n = 1,064, response rate = 82%) were recruited through participating urologists and hospital outpatient clinics in Queensland, Australia, and completed telephone interviews and self-administered questionnaires. Outcome measures were the diagnostic interval (initial consultation to definitive diagnosis) and treatment interval (definitive diagnosis to start of treatment).

Results

Median time to diagnosis was 73 days (IQR = 41–144) and median treatment interval was 65 days (IQR = 36–107). After adjustment, men were more likely to wait more than 70 days for their definitive diagnosis when they initially presented with symptoms (compared with a general checkup) or did not have private health insurance. For treatment interval, men without private health insurance or who were treated with radiotherapy alone were more likely to wait more than 70 days. Treatment intervals were shorter when men received androgen deprivation therapy combined with radiotherapy.

Conclusions

Differences in waiting times for diagnosis and treatment related to access to private hospital care suggest that there are inequities in health-care service provision that are system based.

Keywords

Prostate cancer Neoplasms Diagnosis Treatment Time intervals 

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Peter D. Baade
    • 1
    • 2
  • Robert A. Gardiner
    • 3
    • 4
  • Megan Ferguson
    • 1
  • Danny R. Youlden
    • 1
  • Joanne F. Aitken
    • 1
    • 5
  • John Yaxley
    • 6
  • Suzanne K. Chambers
    • 7
  1. 1.Viertel Centre for Research in Cancer ControlCancer Council QueenslandFortitude ValleyAustralia
  2. 2.School of Public HealthQueensland University of TechnologyBrisbaneAustralia
  3. 3.University of Queensland Centre for Clinical Research, Royal Brisbane HospitalBrisbaneAustralia
  4. 4.Department of UrologyRoyal Brisbane HospitalBrisbaneAustralia
  5. 5.School of Population HealthUniversity of QueenslandBrisbaneAustralia
  6. 6.Brisbane Private HospitalBrisbaneAustralia
  7. 7.Griffith Health InstituteGriffith UniversityBrisbaneAustralia

Personalised recommendations